Total Payments
$23,541
2024 Payments
$634.63
Companies
30
Transactions
308
Medicare Patients
20,070
Medicare Billing
$3.0M
Payment Breakdown by Category
Other$14,920 (63.4%)
Food & Beverage$7,781 (33.1%)
Travel$430.20 (1.8%)
Education$409.33 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,920 | 8 | 63.4% |
| Food and Beverage | $7,781 | 291 | 33.1% |
| Travel and Lodging | $430.20 | 1 | 1.8% |
| Education | $409.33 | 8 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Esperion Therapeutics, Inc. | $15,540 | 20 | $0 (2021) |
| Abbott Laboratories | $2,946 | 36 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,124 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $662.08 | 68 | $0 (2024) |
| Medtronic Vascular, Inc. | $539.95 | 10 | $0 (2020) |
| Amgen Inc. | $488.05 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $334.33 | 24 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $330.57 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $288.24 | 20 | $0 (2023) |
| Boston Scientific Corporation | $267.59 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $634.63 | 27 | Abbott Laboratories ($218.26) |
| 2023 | $1,182 | 32 | Actelion Pharmaceuticals US, Inc. ($356.84) |
| 2022 | $766.70 | 22 | Abbott Laboratories ($494.16) |
| 2021 | $10,229 | 41 | Esperion Therapeutics, Inc. ($9,316) |
| 2020 | $6,672 | 24 | Esperion Therapeutics, Inc. ($6,224) |
| 2019 | $882.41 | 40 | Abbott Laboratories ($384.33) |
| 2018 | $1,566 | 71 | Abbott Laboratories ($498.10) |
| 2017 | $1,608 | 51 | Medtronic Vascular, Inc. ($464.14) |
All Payment Transactions
308 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $60.98 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/11/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/25/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Genetic Disease | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Varithena_PI | ||||||
| 10/30/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiology | ||||||
| 10/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Obesity | ||||||
| 10/09/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: EndoVenous Therapies | ||||||
| 09/30/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Not Applicable | ||||||
| 09/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: EndoVenous Therapies | ||||||
| 08/19/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $11.16 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/08/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $22.19 | General |
| Category: Heart Failure and Hypertension | ||||||
| 06/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Obesity | ||||||
| 04/29/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Varithena_PI | ||||||
| 04/17/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/15/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $12.69 | General |
| Category: Heart Failure and Hypertension | ||||||
| 03/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Cardiology | ||||||
| 02/27/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $144.48 | General |
| Category: Cardiac Rhythm Management | ||||||
| 02/19/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 4,394 | 5,924 | $2.7M | $641,234 |
| 2022 | 26 | 5,262 | 7,194 | $3.5M | $824,718 |
| 2021 | 25 | 5,233 | 7,090 | $3.3M | $800,074 |
| 2020 | 24 | 5,181 | 6,904 | $3.0M | $691,498 |
Total Patients
20,070
Total Services
27,112
Medicare Billing
$3.0M
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 170 | 170 | $635,800 | $178,994 | 28.2% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 170 | 340 | $510,000 | $77,380 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 590 | 798 | $126,076 | $70,378 | 55.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 405 | 416 | $299,780 | $54,795 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 615 | 705 | $82,314 | $42,826 | 52.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 225 | 900 | $148,500 | $37,253 | 25.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 191 | 225 | $157,500 | $28,121 | 17.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 94 | 94 | $103,400 | $26,672 | 25.8% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 11 | 25 | $132,500 | $19,518 | 14.7% |
| 36482 | Chemical destruction of first incompetent vein of arm or leg using imaging guidance | Office | 2023 | 11 | 16 | $104,000 | $19,084 | 18.3% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 29 | 29 | $53,650 | $16,711 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 141 | 141 | $35,250 | $16,312 | 46.3% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 95 | 190 | $39,900 | $16,103 | 40.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 265 | 265 | $136,475 | $12,528 | 9.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 844 | 1,006 | $95,570 | $9,870 | 10.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 120 | 122 | $39,335 | $5,989 | 15.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 18 | 18 | $9,055 | $2,440 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $2,550 | $1,212 | 47.5% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2023 | 145 | 145 | $2,900 | $1,144 | 39.5% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 22 | 22 | $12,320 | $1,027 | 8.3% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 13 | 13 | $3,250 | $847.56 | 26.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 153 | 157 | $5,063 | $845.37 | 16.7% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 39 | 39 | $4,290 | $711.14 | 16.6% |
| G0250 | Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Office | 2023 | 11 | 71 | $2,130 | $474.28 | 22.3% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2022 | 230 | 230 | $860,200 | $244,990 | 28.5% |
About Dr. Amy Kingman, M.D
Dr. Amy Kingman, M.D is a Cardiovascular Disease healthcare provider based in Macon, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992749659.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Kingman, M.D has received a total of $23,541 in payments from pharmaceutical and medical device companies, with $634.63 received in 2024. These payments were reported across 308 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,920).
As a Medicare-enrolled provider, Kingman has provided services to 20,070 Medicare beneficiaries, totaling 27,112 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Macon, GA
- Active Since 06/15/2006
- Last Updated 09/29/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1992749659
Products in Payments
- NEXLIZET (Drug) $13,274
- NEXLETOL (Drug) $2,114
- Confirm Rx (Device) $682.87
- XARELTO (Drug) $644.88
- VenaSeal (Device) $522.11
- OPSUMIT MACITENTAN (Drug) $499.64
- UPTRAVI (Drug) $458.62
- Repatha (Biological) $442.12
- AVEIR (Device) $438.07
- ELIQUIS (Drug) $374.41
- QUADRA ASSURA (Device) $365.50
- Merlin Connectivity and Remote (Device) $326.35
- ENTRESTO (Drug) $282.46
- BRILINTA (Drug) $241.78
- Pacemakers (Device) $186.21
- FLEXITOUCH (Device) $181.66
- CRT-Ds (Device) $160.50
- Varithena Administration Pack (Device) $142.99
- MRI Ready Leads (Device) $119.08
- Quadra Assura CRT Defibrillator (Device) $115.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Macon
Erskine James, Md, MD
Cardiovascular Disease — Payments: $127,121
Cardiovascular Disease $127,121
William Knopf, Md, MD
Cardiovascular Disease — Payments: $44,690
Cardiovascular Disease $44,690
Mr. Julius Elmore, M.d, M.D
Cardiovascular Disease — Payments: $43,243
Cardiovascular Disease $43,243
Dr. Daniel Haithcock, M.d, M.D
Cardiovascular Disease — Payments: $41,272
Cardiovascular Disease $41,272
Onajefe Nelson-Twakor, Md, MD
Cardiovascular Disease — Payments: $31,714
Cardiovascular Disease $31,714
Carmine Oddis, M.d, M.D
Cardiovascular Disease — Payments: $28,173
Cardiovascular Disease $28,173